KRYSTINA BROWNING: Open Payments
NPI 1598239287 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 81 payments from 21 companies in 2025. Trend: 2023 $1,820 · 2024 $1,352 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $247 |
| JAZZ PHARMACEUTICALS INC. | 14 | $166 |
| Verona Pharma, Inc. | 8 | $166 |
| HARMONY BIOSCIENCES LLC | 7 | $134 |
| QOL Medical, LLC | 5 | $128 |
| Madrigal Pharmaceuticals | 3 | $93 |
| Grifols USA, LLC | 4 | $71 |
| Amgen Inc. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
Products named: Ohtuvayre, TRELEGY ELLIPTA, WAKIX, Sucraid, NUCALA, REZDIFFRA, Prolastin-C Liquid, TEZSPIRE.
Industry payments across KY — which companies pay providers there.
